In addition, loss of Kindlin-1 in patients with Kindler Syndrome (KS) promotes tumorigenesis, with KS patients having a propensity to develop highly aggressive cutaneous squamous cell carcinoma (cSCC) [12–14]. The gene discussed is FERMT1; the disease is cutaneous squamous cell carcinoma.